#Midkine (MDK) may help slow amyloid buildup in #Alzheimers disease. New findings show MDK reduces aggregation of Aβ40 and Aβ42 into fibrils, while loss of MDK increased plaque formation and microglial activation in AD mouse models.
t.ly/T9XdJ
#Neuroscience #BetaAmyloid #RDStartsHere #rPeptide
A recent study shows that serum #Midkine suppresses #OsteoblastDifferentiation via the #PI3K-AKT pathway and increases #Inflammatory #Cytokines via the #NFκB pathway, promising a therapeutic target for postmenopausal #Osteoporosis. #medsky
#OpenAccess: www.sciencedirect.com/science/arti...
Tiny Protein Confirmed to Dismantle the Toxic Clumps Linked to Alzheimer’s Disease: Scientists at St. Jude Children’s Research Hospital have demonstrated for the first time that the protein midkine plays a preventative role in… @goodnewsnetwork.org #Alzheimers #Research #Science #Midkine #Health
This study reveals the growth factor Midkine (MDK) triggers a potent autocrine mechanism that deactivates NR2F1-dependent dormancy in DCCs, favoring metastatic outgrowth. This means MDK essentially "wakes up" dormant melanoma cells! #MIDKINE #NR2F1 #DDCs
So excited and proud to be a co-author on our new preprint: "Midkine inhibits dormancy of disseminated melanoma cells." Huge congrats to Carolina Rodriguez-Tirado & Maria Soledad Sosa for leading this fantastic work! 🎉 #MelanomaResearch #CancerDormancy #Midkine